3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
3
Other hematologic neoplasm
2
Plasma cell
1
Gastrointestinal
1
Conditions
Multiple Myeloma
873
Neoplasms, Plasma Cell
162
Lymphoma, Non-Hodgkin
139
Lymphoma
135
Hodgkin Disease
134
Leukemia, Lymphocytic, Chronic, B-Cell
118
Precursor Cell Lymphoblastic Leukemia-Lymphoma
109
Myelodysplastic Syndromes
103
Recurrence
101
Leukemia, Myeloid, Acute
99
Leukemia
94
Lymphoma, Mantle-Cell
80
Lymphoma, Large B-Cell, Diffuse
76
Lymphoma, Follicular
73
Myeloproliferative Disorders
69
Lymphoma, B-Cell, Marginal Zone
69
Hematologic Neoplasms
64
Burkitt Lymphoma
64
Primary Myelofibrosis
57
Lymphoma, Large-Cell, Immunoblastic
55
Waldenstrom Macroglobulinemia
52
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
52
Leukemia, Myeloid, Chronic-Phase
46
Lymphoma, T-Cell, Cutaneous
44
Immunoglobulin Light-chain Amyloidosis
43
Congenital Abnormalities
43
Neoplasms
41
Leukemia, Myelomonocytic, Chronic
41
Leukemia, Myeloid, Accelerated Phase
40
Sezary Syndrome
38
Interventions
Vaccines
1
Influenza Vaccines
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Influenza, Human
×
Plasma cell
×
Clear all
NCT02566265
2019-01-30
SHIVERING 2
Yale University
Phase 2
Completed
122 enrolled
10 charts